Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
20/20 Gene Systems
20/20 BioLabs, formerly 2020 GeneSystems, develops and commercializes AI-powered laboratory blood tests for the early detection and prevention of cancers and chronic diseases. Their OneTest™ for…
20/20 Gene Systems
20/20 BioLabs, formerly 2020 GeneSystems, develops and commercializes AI-powered laboratory blood tests for the early detection and prevention of cancers and chronic diseases. Their OneTest™ for…
TL;DR
Founded: May 2000
Headquarters: Rockville, Maryland, United States
Core product: Blood-based cancer early-detection and biomarker tests (OneTest for Cancer; OneTest for Longevity)
Funding type: Equity crowdfunding (Reg A+)
Approx. employees: 29
Company Overview
Problem Domain
Early detection of cancer and monitoring biomarkers for chronic disease and healthy aging
Founded
2000
Industry
Biotechnology / Diagnostics
Funding Track Record
more than $5,000,000
Company-reported retail crowdfunding; materials also reference retail and accredited investor opportunities.
14370000.00
Aggregate funding amount in provided snapshot data.
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
83,000+
Open Roles
4,300+
New This Week